Does Extended Interval Dosing Natalizumab Preserve Effectiveness in Multiple Sclerosis? A 7 Year-Retrospective Observational Study - Docwire News Doc Wire News, 12 Apr 2021 This article was originally published here Front Immunol. 2021 Mar 25;12:614715.